Table 1.

Patient survival and tumor-free survival in patients with intrahepatic cholangiocarcinoma and mixed hepatocellular-cholangiocarcinoma

Ref.	n	No. of iCCA/HCC-CC	Patient survival (%)			Tumor-free survival (%)
			1-yr	3-yr	5-yr	1-yr	3-yr	5-yr
O'Grady et al[76]	13	13 iCCA	38	10	10	-	-	-
Yokoyama et al[77]	2	2 iCCA	50	0	-	-	-	-
Pichlmayr et al[78]	18	18 iCCA	13.9	0	-	-	-	-
Pichlmayr et al[78]	22	22 iCCA	20.8	0	-	-	-	-
Casavilla et al[55]	20	20 iCCA	70	29	18	67	31	31
Shimoda et al[63]	16	8 iCCA	62	39	-	70	35	-
		8 HCC-CC
Robles et al[27]	23	23 iCCa	77	65	42	68	45	27
Ghali et al[56]	10	9 iCCA	-	30	-	-	-	-
		1 HCC-CC
Fu et al[66]	11	11 iCCA	50.5	50.5	-	51.9	51.9	-
Sapisochin et al[64]	14	6 iCCA	79	66	47	60	50	30
		8 HCC-CC
Vallin et al[65]	10	10 iCCA	80	60	24	40	50	50
Sapisochin et al[68]	29	29 iCCA	79	61	45	89	71	71
	≤ 2 cm	8 iCCA	100	73	73	0	0	0
	Multiple or single > 2 cm	21 iCCA	71	43	43	74	58	58
Facciuto et al[71]	32	16 iCCA	71	-	57	62	-	44
		16 HCC-CC

iCCA: Intrahepatic cholangiocarcinoma; HCC-CC: Hepatocellular-cholangiocarcinoma.